etoposide has been researched along with Bile Duct Obstruction, Extrahepatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawada, S; Kondo, H; Ootani, I; Sato, T; Shibata, T; Suzuki, H | 1 |
| Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Reed, G; Wolff, SN | 1 |
2 other study(ies) available for etoposide and Bile Duct Obstruction, Extrahepatic
| Article | Year |
|---|---|
[Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cholestasis, Extrahepatic; Common Bile Duct Neoplasms; Etoposide; Female; Floxuridine; Humans; Male; Middle Aged; Picibanil; Remission Induction; Tegafur; Uracil | 1990 |
Etoposide kinetics in patients with obstructive jaundice.
Topics: Biliary Tract; Cholestasis; Cholestasis, Extrahepatic; Etoposide; Half-Life; Humans; Hyperbilirubinemia; Kidney; Liver | 1990 |